Costain Group PLC
30 September 2002
COSTAIN GROUP PLC
COSTAIN WINS FIRST CONTRACT IN THE MIDLANDS
Costain, which earlier this year established a regional office in the Midlands,
located at the Birmingham Business Park, has won a £13 million contract to
construct new facilities at the Royal Shrewsbury Hospital.
The development, which will be completed in 16 months, includes a 32 bed medical
assessment unit, 36 bed elderly care and rehabilitation unit, pre-operative
assessment clinic, MRI scanner imaging department and clinical office
accommodation.
Costain, with a pedigree stretching back to 1865, is one of the UK's best-known
building and engineering companies. In the autumn 2001, the company announced an
aggressive growth strategy that included launching a new Midlands business.
Tom Caulcott, Chairman of the Royal Shrewsbury Hospital, said:
'We are delighted that a company with the expertise and track record of Costain
has secured this contract. This project represents the most important investment
in Shropshire this decade. We look forward to working with Costain to produce a
facility of which we can all be proud.'
Costain director, Mike Thompson, said:
'We've only been in our new home for a few months and to have already won such
an important contract is testimony to the reputation that Costain has both
across the industry and in the sectors in which we intend to be a force.'
30 September 2002
Enquiries:
Costain Tel. 01628 842444
Graham Read
College Hill Tel. 020 7457 2020
Mark Garraway
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.